相关实验视频

Updated: Sep 19, 2025

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders

Published on: April 28, 2023

威尔逊病中的生物标志物发现 - - 改善诊断和管理的途径:综合性审查

Marta Wolska^1,2, Zofia Wicik¹, Sara Ahmadova^1,2

¹Department of Experimental and Clinical Pharmacology, Center for Preclinical Research and Technology CEPT, Medical University of Warsaw, Banacha 1B Str, 02-097, Warsaw, Poland.

Molecular neurobiology

|June 18, 2025

概括

新的生物标志物显示出诊断威尔逊病 (WD) 和监测其进展的前景. 识别这些分子标记物可能会导致更早的检测和更好的治疗策略,这种罕见的铜代谢障碍.

科学领域:

生物化学生物化学
遗传学是一个遗传学.
临床医学临床医学

背景情况:

威尔逊病 (WD) 是一种罕见的铜代谢遗传疾病,导致肝脏和神经损伤.
可变的临床表现往往会延迟诊断,增加不可逆转并发症的风险.
目前的诊断方法缺乏足够的准确性,需要新的生物标志物.

研究的目的:

审查威尔逊病肝脏和神经系统表现的新兴生物标志物.
突出这些标记物在早期诊断和治疗监测方面的潜力.
讨论这些发现对改善患者治疗结果的影响.

主要方法:

关于威尔逊病生物标志物的最近研究的文献综述.
分析基于血液的分子标记物,包括细胞因子,蛋白酶和炎症体.
基于代谢,蛋白质和微RNA的签名的探索.

主要成果:

神经纤维光链 (NfL),素3 (PTX3) 和NLRP3炎症酶激活是潜在的神经标志物.
可溶性CD163 (sCD163) 和亡抗原1 (APO-1) 在评估肝功能障碍方面表现有前途.
代谢和microRNA配置文件可以区分WD亚型和跟踪疾病进展.

结论:

新兴的生物标志物为提升威尔逊病的早期诊断提供了潜力.
这些标记物可以帮助预测神经衰退和优化治疗干预措施.
进一步的研究和标准化对于将这些生物标志物纳入临床实践至关重要.

关键词:

早期诊断早期诊断早期诊断神经系统的损伤,神经系统的损伤.新型生物标志物新型生物标志物处理过程的监控.威尔逊病是威尔逊病的一种疾病.

更多相关视频

Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides

Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides

Published on: September 7, 2019

Author Spotlight: Investigating Hepatic Adaptations and Prediabetic Progression in Liver Diseases

Author Spotlight: Investigating Hepatic Adaptations and Prediabetic Progression in Liver Diseases

Published on: October 6, 2023

相关概念视频

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

Lysosomal Hydrolases

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...